Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloid Beta Protein”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Not applicableLooking for participantsNCT07402356
What this trial is testing

VR Pupillometry in Cognitive Impairment

Who this might be right for
Alzheimer s DiseaseMajor Depressive Disorder (MDD)Mild Cognitive Impairment+1 more
Max-Planck-Institute of Psychiatry 140
Not applicableStudy completedNCT01425957
What this trial is testing

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

Who this might be right for
MILD COGNITIVE IMPAIRMENT
Qualissima 229
Early research (Phase 1)Ended earlyNCT00605059
What this trial is testing

Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 3
Very early researchEnded earlyNCT01000870
What this trial is testing

Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 6
Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944
What this trial is testing

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Who this might be right for
Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more
Michael Rafii, MD, PhD 60
Not applicableStudy completedNCT02474251
What this trial is testing

Brain Sleep Clearance of Amyloid-Beta Peptides

Who this might be right for
Obstructive Sleep ApneaAlzheimer's Disease
NYU Langone Health 38
Early research (Phase 1)Study completedNCT00439010
What this trial is testing

Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects

Who this might be right for
Alzheimers Disease
Molecular NeuroImaging 30
Early research (Phase 1)Study completedNCT00287248
What this trial is testing

Assess 123-I IMPY and SPECT Imaging as a Tool to Detect β-Amyloid in the Brain

Who this might be right for
Alzheimer Disease
Institute for Neurodegenerative Disorders 38
Testing effectiveness (Phase 2)UnknownNCT04926272
What this trial is testing

Amyloid-beta PET Imaging With 18F-92 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
First Affiliated Hospital of Fujian Medical University 50
Early research (Phase 1)Study completedNCT01978548
What this trial is testing

Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 45
Not applicableStudy completedNCT01982578
What this trial is testing

Genistein as a Possible Treatment for Alzheimer's Disease.

Who this might be right for
Alzheimer's Disease
Fundación para la Investigación del Hospital Clínico de Valencia 27
Early research (Phase 1)Study completedNCT00765115
What this trial is testing

Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 27
Post-approval studies (Phase 4)Study completedNCT02161458
What this trial is testing

Escitalopram Effects on CSF Amyloid Beta

Who this might be right for
Amyloid Beta Protein
University of Pennsylvania 98
Early research (Phase 1)Ended earlyNCT00886951
What this trial is testing

Single Photon Emission Computed Tomography (SPECT) Imaging Study to Develop a Biomarker for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Institute for Neurodegenerative Disorders 2
Large-scale testing (Phase 3)Study completedNCT01561053
What this trial is testing

Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 347
Testing effectiveness (Phase 2)Ended earlyNCT00500500
What this trial is testing

Effect of EGb 761® on Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Ipsen 40
Post-approval studies (Phase 4)Study completedNCT00046358
What this trial is testing

The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
National Institute of Mental Health (NIMH) 50
Not applicableStudy completedNCT01189084
What this trial is testing

Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
United Biomedical 14
Not applicableUnknownNCT01128725
What this trial is testing

Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nice 100
Post-approval studies (Phase 4)Study completedNCT00551161
What this trial is testing

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Northwell Health 12
Load More Results